Gynecomastia and hypertension in a patient treated with posaconazole

Date Issued
2020-01-01
Author(s)
Thompson, George R.
Surampudi, Prasanth N.
DOI
10.1002/ccr3.3376
Abstract
Posaconazole therapy may lead to increased serum estradiol levels and development of gynecomastia. Early detection by endocrine hormone measurements may help preventing gynecomastia.
File(s)
Loading...
Thumbnail Image
Name

ccr3.3376.pdf

Size

116.77 KB

Format

Adobe PDF

Checksum

(MD5):dcdf2ea3ecfd03058fa1bce436cdf9ea